Aortic Repair Devices – Market Insights – Asia Pacific

The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent graft technology and changes in the prices of the endovascular grafts. Nevertheless, several factors will partially constrain procedural growth, including insufficient numbers of physicians trained in endovascular methods, limited aneurysm awareness and screening programs, and budget-restricted healthcare infrastructure across select covered markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Asia Pacific from 2019 to 2034.

The aortic stent graft market is driven by continuous innovation, with companies introducing devices capable of treating increasingly complex aneurysms.

Which types of aortic stent grafts are currently available in Asia-Pacific and for which anatomies? Which types of products are expected to enter the market

How will the introduction of new branched stent grafts will drive the adoption of customized procedures in each country?

How will these products influence the volume of aortic surgical procedures?

How will these products impact the competitive landscape in Asia-Pacific?

The endovascular treatment of aortic aneurysms will expand robustly during the forecasted period.

In which indications will endovascular procedures experience the highest growth?

What impact will the increasing availability of branched endografts have on the competitive landscape in the coming years?

Which country will see the fastest growth of endovascular aortic repair procedures?

The introduction to the price regulation of aortic stent grafts in China by the NHSA, which has resulted in a significant reduction in prices.

How will thoracic stent graft price adjustments affect the market?

How will the new pricing regulation impact the revenues of major market competitors?